NRXP - NRX Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NRXP is currently covered by 2 analysts with an average price target of $23. This is a potential upside of $20.51 (823.69%) from yesterday's end of day stock price of $2.49.

NRX Pharmaceuticals's activity chart (see below) currently has 9 price targets and 27 ratings on display. The stock rating distribution of NRXP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 292 days.

Highest price target for NRXP is $34, Lowest price target is $10, average price target is $23.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 01-Oct-2026. First documented stock forecast 30-Jun-2022.

Best performing analysts who are covering NRXP - NRX Pharmaceuticals:

Vernon Bernardino Edward Woo Jason Kolbert Thomas Shrader Patrick Trucchio

Currently out of the existing stock ratings of NRXP, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Nov-2022

24 days ago
(01-Oct-2026)

1/3 (33.33%)

$43.3 (646.27%)

245

Buy Since 02-Apr-2025

$10

$7.51 (301.61%)

$10

1 months 11 days ago
(14-Sep-2026)

0/4 (0%)

$6.51 (186.53%)

Buy Since 22-Aug-2025

$34

$30.27 (811.53%)

$34

5 months 20 days ago
(05-May-2026)

0/5 (0%)

$30.96 (1018.42%)

Buy Since 08-Sep-2025

$40

7 months 22 days ago
(03-Mar-2026)

1/2 (50%)

$37.16 (1308.45%)

769

Buy Since 30-Jun-2022

$40

$36.27 (972.39%)

$19

1 years 9 days ago
(16-Oct-2025)

4/6 (66.67%)

$36.96 (1215.79%)

441

Show more analysts

Please expand the browser size to see the chart

What is NRXP (NRX Pharmaceuticals) average time for price targets to be met?

On average it took 292 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on NRXP (NRX Pharmaceuticals)?

Edward Woo

Which analyst has the most public recommendations on NRXP (NRX Pharmaceuticals)?

Edward Woo works at ASCENDIANT and has 5 price targets and 5 ratings on NRXP

Which analyst is the currently most bullish on NRXP (NRX Pharmaceuticals)?

Vernon Bernardino with the highest potential upside of $36.27

Which analyst is the currently most reserved on NRXP (NRX Pharmaceuticals)?

Vernon Bernardino with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?